What is Orbactiv
Orbactiv (oritavancin) is a lipoglycopeptide antibiotic that is used to treat skin and soft tissue infections, including diabetic foot infections, bone and joint infections, and pneumonia. Orbactiv is in a class of antibiotics called lipoglycopeptides, which are derived from glycopeptides. Orbactiv is unique among lipoglycopeptides in that it is a single-dose, 30-minute infusion.
Benefits of Orbactiv
and Its Uses.
Orbactiv is a medication that is used to treat bacterial infections. It is a type of antibiotic that is known as a lipoglycopeptide. This medication is available as a pill or as an injection.
Orbactiv is used to treat a number of different types of bacterial infections, including pneumonia, skin infections, and infections that occur in the urinary tract or the abdomen. It is also used to prevent infections in people who are at risk of developing them, such as those who have had surgery or who are receiving chemotherapy.
Orbactiv is a very effective antibiotic, and it is usually well tolerated. However, there are some side effects that can occur, including nausea, vomiting, diarrhea, and constipation.
Side Effects and Dosage of Orbactiv
Orbactiv (oritavancin) is a semisynthetic lipoglycopeptide antibiotic indicated in the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Enterococcus faecalis, and Enterococcus faecium.
The recommended dosage of Orbactiv is an 800 mg IV loading dose, followed by a 400 mg IV dose every 12 hours for a total of 7 to 10 days.
Orbactiv may cause serious side effects, including:
• Infusion reactions: tell your healthcare provider if you have any signs or symptoms of an infusion reaction, including fever, chills, shortness of breath, chest pain, or rapid heart rate.